ConductScience.org, home

Paper68962

The behavior of alpha2-plasmin inhibitor in fibrinolytic states.

Aoki N and 3 others. J Clin Invest, 1977. Cited by 159 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The behavior of alpha2-plasmin inhibitor in fibrinolytic states. Papers, record 68962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68962

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
PubMed
Journal
J Clin Invest
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
159
iCite
Relative citation ratio, by iCite
5.21
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aoki NN
2Moroi MM
3Matsuda MM
4Tachiya KK

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alpha-GlobulinsMajor topic
FibrinolysinMajor topic
FibrinolysisMajor topic
Fibrinogen
Humans
Immunoelectrophoresis
Kinetics
Plasminogen
Plasminogen Activators
Plasminogen Inactivators
Urokinase-Type Plasminogen Activator

Source PubMed

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,080,301Immunochemical distinction between antiplasmin and alpha-antitrypsin.Thromb Res1975https://conductscience.org/library/papers/1080301PubMed
2127,607Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum.Br J Haematol1975https://conductscience.org/library/papers/127607PubMed
3131,986Inhibition of plasmin by normal and antiplasmin-depleted human plasma.Thromb Res1976https://conductscience.org/library/papers/131986PubMed
4134,465Immunochemical distinction between the inhibitors of plasminogen activation and antiplasmin in human plasma.Thromb Res1976https://conductscience.org/library/papers/134465PubMed
5134,998Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.J Biol Chem1976https://conductscience.org/library/papers/134998PubMed
613,664,784The mechanism of clot dissolution by plasmin.J Clin Invest1959https://conductscience.org/library/papers/13664784PubMed
714,081,261THE INFLUENCE OF INORGANIC SALTS ON PLASMA ANTITHROMBIN ACTIVITY.Thromb Diath Haemorrh1963https://conductscience.org/library/papers/14081261PubMed
814,097,352THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.Biochem J1963https://conductscience.org/library/papers/14097352PubMed
914,253,483A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD.J Exp Med1965https://conductscience.org/library/papers/14253483PubMed
1014,302,464ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.Anal Biochem1965https://conductscience.org/library/papers/14302464PubMed
134,114,0142 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase.Scand J Clin Lab Invest1972https://conductscience.org/library/papers/4114014PubMed
144,114,358Electroimmuno assay.Scand J Clin Lab Invest Suppl1972https://conductscience.org/library/papers/4114358PubMed
154,237,416Molecular weight studies on human plasminogen and plasmin at the microgram level.J Biol Chem1969https://conductscience.org/library/papers/4237416PubMed
164,249,466The influence of inhibitors of plasmin and plasminogen activation on the streptokinase-induced fibrinolytic state.Thromb Diath Haemorrh1970https://conductscience.org/library/papers/4249466PubMed
174,251,631Human serum plasminogen antiactivator: its distinction from antiplasmin.Am J Physiol1971https://conductscience.org/library/papers/4251631PubMed
184,251,763Plasminogen-plasmin system. VI. Preparation of alpha 2-macroglobulin antiplasmin from human plasma.Biochim Biophys Acta1970https://conductscience.org/library/papers/4251763PubMed
194,275,737Distinction of serum inhibitor of activator-induced clot lysis from alpha1-antitrypsin.Proc Soc Exp Biol Med1974https://conductscience.org/library/papers/4275737PubMed
204,276,455The inhibition of human plasmin by human antithrombin-heparin cofactor.J Biol Chem1974https://conductscience.org/library/papers/4276455PubMed
214,282,470Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.Biochem J1974https://conductscience.org/library/papers/4282470PubMed
224,543,991Studies on an inhibitor of plasminogen activation in human serum.Thromb Diath Haemorrh1973https://conductscience.org/library/papers/4543991PubMed

See all 29 references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.

PMIDTitleJournalYearIn PapersSource
39,504,559Use of Affimer technology for inhibition of α2-antiplasmin and enhancement of fibrinolysis.Blood Adv2025https://conductscience.org/library/papers/39504559PubMed
38,395,065Fibrinolysis-Mediated Pathways in Acute Liver Injury.Semin Thromb Hemost2024https://conductscience.org/library/papers/38395065PubMed
34,406,905Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.Am J Physiol Cell Physiol2021https://conductscience.org/library/papers/34406905PubMed
27,472,428α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.Semin Thromb Hemost2017https://conductscience.org/library/papers/27472428PubMed
18,674,818Biological activities of C1 inhibitor.Mol Immunol2008https://conductscience.org/library/papers/18674818PubMed
7,199,538Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.J Clin Invest1982https://conductscience.org/library/papers/7199538PubMed
6,786,463Acquired alpha 2 antiplasmin deficiency in glomerular proteinuria.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6786463PubMed
6,444,305Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.J Clin Invest1980https://conductscience.org/library/papers/6444305PubMed
6,388,669Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli.Blut1984https://conductscience.org/library/papers/6388669PubMed
6,166,634Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.J Clin Invest1981https://conductscience.org/library/papers/6166634PubMed
3,166,140Organization of the human alpha 2-plasmin inhibitor gene.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3166140PubMed
3,038,753Identification of a specific receptor for plasmin on a group A streptococcus.Infect Immun1987https://conductscience.org/library/papers/3038753PubMed
2,526,671Clinical disorders of fibrinolysis: a critical review.Blut1989https://conductscience.org/library/papers/2526671PubMed
2,496,145Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.J Clin Invest1989https://conductscience.org/library/papers/2496145PubMed
2,419,360Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.J Clin Invest1986https://conductscience.org/library/papers/2419360PubMed
659,588Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis.J Clin Invest1978https://conductscience.org/library/papers/659588PubMed
156,364Inhibitory spectrum of alpha 2-plasmin inhibitor.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/156364PubMed
156,196Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.J Clin Invest1979https://conductscience.org/library/papers/156196PubMed
151,804The human plasma fibrinolytic system: regulation and control.Mol Cell Biochem1978https://conductscience.org/library/papers/151804PubMed

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
A2M2PubTator's text mininghttps://conductscience.org/library/genes/2NCBI Gene
PLAU5,328PubTator's text mininghttps://conductscience.org/library/genes/5328NCBI Gene
PLG5,340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINA15,265PubTator's text mininghttps://conductscience.org/library/genes/5265NCBI Gene
SERPINF25,345PubTator's text mininghttps://conductscience.org/library/genes/5345NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/68962

GET https://conductscience.org/api/papers/v1/68962/references?page=2